09/18/2017 - 6:36pm
Health consumers migrating to retail

Health economist Jane Sarasohn-Kahn highlighted the economic stresses Americans face as they grapple with rising out-of-pocket costs at the Health Innovation Summit, co-hosted in June by CVS Health in partnership with DSN and Mack Elevation.

09/18/2017 - 4:34pm
FDA approves Symbiomix Therapeutics’ Solosec

Solosec is the first approved single-dose oral therapy for bacterial vaginosis. 

09/18/2017 - 4:13pm
Q&A: Doyle Jensen on central fill’s potential for community pharmacists

Drug Store News caught up with Innovation VP global business development Doyle Jensen to discuss the company’s role in enabling community pharmacists to better serve patients through technology.

09/18/2017 - 2:29pm
CNBC’s retail ‘fixer’ Marcus Lemonis headlines Emerson Group 10th Annual Industry Day

As successful retail strategies continue to demand a greater degree of sophistication, The Emerson Group 10th Annual Industry Day delivers a thought leadership platform that challenges the status quo. 

09/18/2017 - 2:24pm
Lupin names new chief corporate development officer

Jim Loerop with lead the company's business development and mergers and acquisitions functions as the company ramps up its move into the complex generics and specialty branded segments.

09/18/2017 - 2:06pm
Perrigo gets tentative FDA nod for Acanya generic

The acne treatment had U.S. sales of roughly $57 million for the 12 months ended July 2017, Perrigo said.

09/15/2017 - 2:12pm
Pharmacy joins expanded roster of TelaCare offerings

The company on Friday announced the addition of pharmacists consultations, as well as consultations with dentists, optometrists, dietitians, sports medicine and alternative medicine professionals, to its offerings.

09/15/2017 - 12:38pm
KKR's Internet Brands closes WebMD deal

Upon completion of the merger, WebMD will become a wholly owned subsidiary and WebMD's common stock will cease trading on the NASDAQ.

09/14/2017 - 3:56pm
FDA approves first biosimilar cancer treatment

Mvasi, a biosimilar of Avastin, is indicated to treat five types of cancer. 

09/14/2017 - 3:04pm
Mylan intros generic Minastrin 24 Fe

The product had U.S. sales of roughly $346.9 million for the 12 months ended July 31, according to QuintilesIMS data.